Factors affecting the quercetin niosomes prepared by proniosome gel method
Main Article Content
Abstract
The objective of this study was to investigate factors affecting the characteristics and stability of quercetin noisomes prepared by proniosome method. Nonionic surfactant used in the study was Brij®98 and the factors in the study were the pH of phosphate buffer, quantity of incorporated quercetin and the present of dihexadecyl phosphate as lipid modifier. Eight formulas of quercetin niosomes were prepared by proniosome gel method which were then diluted with phosphate buffer to form niosomes. The resulted quercetin niosomes were evaluated for sizes, entrapment efficiency and morphology. The stability was evaluated by measuring the size after storage at 25ºC up to 1 month. The best formula was prepared from Brij®98 with 0.02 g of quercetin, phosphate buffer pH 6.0 and with 0.005 g of dihexadecyl phosphate. Photomicrograph of quercetin niosomes visualized by transmission electron microscope (TEM) revealed that the particles were sphere. This formula was subsequently studied the effect of dilution amount of buffer on sizes. It was found that the higher in amounts of diluting buffer were used, the lower in particle sizes were resulted.
Article Details
In the case that some parts are used by others The author must Confirm that obtaining permission to use some of the original authors. And must attach evidence That the permission has been included
References
Ammar HO, Ghorab M, El-Nahhas SA, et al. Proniosome as a carrier system for transdermal delivery of tenoxicam. International Journal of Pharmaceutics. 2011; 405: 142-152
Boots AW, Haenen GRMM, Bast A. Health effects of quercetin: From antioxidant to nutraceutical. European Journal of Pharmacology 2008: 325-337
Fang JY, Song YY, Wu PC, et al. In vitro skin permeation of estradiol from various proniosome formulation. International Journal of Pharmaceutics 2001; 215: 91-99
Harwood M, Danielewska-Nikiel B. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinotoxic propoties. Food and Chemical Toxicology 2007; 45: 2179-2205
Kumar PG, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery.Acta Pharmaceutica Sinica2011; 1(4): 208-219
Saroha K, Nanda S, Yadav N. Proniosome gel: Potential carrier system in topical/transdermal delivery for drug and cosmetic/cosmeceuticals. 2010. www.pharmainfo.net
Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. International Journal of Pharmaceutics 1998; 172: 33-70
Vora B, Khopade AJ, Jain NK. Proniosome based transdermal delivery of levonorgestrel for effective contraception. Journal of Controlled Release 1998; 54: 149-165